Precision medicine is being developed within a complex landscape of public policy, science, economics, law, and regulation. In these and other policy areas, the goal of developing individually-tailored therapies poses novel challenges for health care research, delivery and policy. In this symposium, a range of experts in genetics, medicine, bioinformatics, intellectual property, health economics and bioethics identified and discussed many of the pressing questions raised by the development and practice of precision medicine. These and other issues will need to be taken into account as precision medicine moves ahead and becomes the standard of medical practice and care in the United States and around the world.
Coonrod, Emily; Contreras, Jorge L.; Dere, Willard; Botkin, Jeffrey; Francis, Leslie; and Tabery, Jim, "Frontiers in Precision Medicine II: Cancer, Big Data and the Public" (2017). Utah Law Faculty Scholarship. 74.